Score Breakdown
Dilution Forecast
Market Data
Source-Backed Evidence Depth
This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.
| Field | Current Value | Basis |
|---|---|---|
| DilutionScore | 48/100 | DilutionWatch score record |
| Shares Outstanding | 85.31M | Verified float table or market cache |
| Public Float | 52.94M | Verified float table or market cache |
| Market Cap | $897.50M | Market data cache |
| Cash Runway | 7.5 months | DilutionWatch score inputs |
| Shelf Capacity | None in current score inputs | SEC-derived dilution fields |
| ATM Capacity | None in current score inputs | SEC-derived dilution fields |
| Outstanding Warrants | None in current score inputs | SEC-derived dilution fields |
Recent source-backed SEC insight records available on this page: 1.
Recent SEC source mix: XBRL 1.
The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.
GLUE SEC Filing Activity — Last 12 Months
Shares outstanding reported by GLUE on the cover page of its latest 10-K/10-Q: 85.31M as of July 31, 2026.
DilutionWatch recorded no shelf, registration or prospectus documents for GLUE in the last 12 months. Full filing list on SEC EDGAR →
| Form | What it is | Filings | Most recent |
|---|---|---|---|
| 8-K | current report (material event) | 5 | Oct 01, 2026 |
| 10-K | annual report | 1 | Mar 17, 2026 |
| 10-Q | quarterly report | 2 | Aug 06, 2026 |
| 3 | initial insider ownership | 5 | Jul 08, 2026 |
| 5 | annual insider ownership | 25 | Jul 06, 2026 |
Institutional Holdings
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Recent SEC Activity
Recent News
Factual GLUE Dilution Snapshot
Monte Rosa Therapeutics, Inc. (GLUE) has a DilutionScore of 48/100, rated Medium dilution risk. Score date: October 27, 2026.
- Recent SEC activity tracked for GLUE: xbrl on 2021-08-12.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
DilutionScore History — Last 90 Days
GLUE's DilutionScore is currently 48/100 (Medium risk), with 1 score change tracked over 89 days. The score improved from 41/100 (Medium risk).
| Period | Score | Risk Level | Duration |
|---|---|---|---|
| Aug 22 – Oct 27, 2026 | 48/100 | MEDIUM | 67 days |
| Jul 30 – Aug 21, 2026 | 41/100 | MEDIUM | 22 days |
Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.
Share Dilution History
GLUE shares outstanding have increased 10.8% from 76.24M (Mar 2026) to 84.48M (May 2026). Each increase represents potential dilution to existing shareholders.
| Date | Shares Outstanding | Public Float | Change |
|---|---|---|---|
| May 31, 2026 | 84.48M | 52.94M | ▼ 0.11% |
| May 24, 2026 | 84.48M | 52.99M | ▲ 0.01% |
| May 18, 2026 | 84.48M | 52.98M | ▼ 14.09% |
| May 15, 2026 | 84.48M | 61.67M | ▲ 0.04% |
| May 12, 2026 | 84.48M | 61.65M | ▲ 2.25% |
| May 09, 2026 | 84.38M | 60.29M | ▲ 5.38% |
| May 01, 2026 | 80.02M | 57.21M | ▲ 0.01% |
| Apr 11, 2026 | 80.02M | 57.20M | ▼ 0.03% |
| Mar 21, 2026 | 80.02M | 57.22M | ▲ 0.41% |
| Mar 20, 2026 | 76.24M | 56.98M | ▲ 22.08% |
| Mar 19, 2026 | 76.24M | 46.68M | ▲ 0.66% |
Share counts sourced from verified regulatory filings. Increases indicate dilution events.
Related Stocks — MEDIUM Risk
Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.